BlackRock Health Sciences Trust II
BMEZ · NYSE
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Revenue | $24,456 | -$384 | $18,291 | $16,605 |
| % Growth | 6,471% | -102.1% | 10.1% | – |
| Cost of Goods Sold | -$3,086 | $3,086 | $3,018 | $3,003 |
| Gross Profit | $27,542 | -$3,470 | $15,272 | $13,602 |
| % Margin | 112.6% | 904% | 83.5% | 81.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | -$2,841 | $3,197 | $3,104 | $0 |
| SG&A Expenses | $49,799 | -$49,443 | $6,562 | $2,288 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $262 | $0 | $0 | $0 |
| Operating Expenses | $50,061 | -$49,443 | $6,562 | $2,288 |
| Operating Income | -$45,046 | $45,973 | $8,711 | $11,314 |
| % Margin | -184.2% | -11,976.7% | 47.6% | 68.1% |
| Other Income/Exp. Net | $22,554 | -$27 | -$4 | -$4 |
| Pre-Tax Income | -$22,492 | $45,947 | $8,707 | $11,310 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$22,492 | $45,947 | $8,707 | $11,310 |
| % Margin | -92% | -11,969.7% | 47.6% | 68.1% |
| EPS | -1.53 | 3.3 | 0.62 | 0.81 |
| % Growth | -146.4% | 432.3% | -23.5% | – |
| EPS Diluted | -1.53 | 3.3 | 0.62 | 0.81 |
| Weighted Avg Shares Out | 13,255 | 13,944 | 13,944 | 13,944 |
| Weighted Avg Shares Out Dil | 13,255 | 13,944 | 13,944 | 13,944 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | -$927 | $0 | $0 | $0 |
| EBITDA | -$22,469 | $45,973 | $8,711 | $11,314 |
| % Margin | -91.9% | -11,976.7% | 47.6% | 68.1% |